XV Konferencja Naukowa Polskiego Towarzystwa Hepatologicznego
Current issue
Archival Issues
Manuscript Submission
Journal Abstract
Non-alcoholic steatohepatitis (NASH) – pathogenesis, diagnosis, treatment
Danuta Dudzik, Małgorzata Knaś, Małgorzata Borzym-Kluczyk, Oxana Lukivskay’a, Vyacheslav Buko, Ewa Dudkiewicz, Katarzyna Knaś-Karaszewska, Sławomir Szajda, Joanna Jakimowicz-Rudy, Sylwia Chojnowska, Katarzyna Niediołko-Bagniuk, Krzysztof Zwierz
Medical Science Review - Hepatologia 2008; 8 48-58
aaICID: 862337
Article type: Review article
IC™ Value: 3.01
Abstract provided by Publisher
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are metabolic liver disorders of increasing importance. There are frequently associated with obesity, diabetes mellitus, hyperlipidemia and insulin resistance. NAFLD can progress to NASH, and NASH to cirhosis, liver failure, and hepatocellular carcinoma. Many drugs have been tried in treatment of NASH. The insulin sensitizing medicines as metformin, thiazolidinediones, antioxidant treatment, have shown promising results. Unfortunately, there is lack of controlled trials of growing numbers of anti-NASH drugs.

ICID 862337

Related articles
  • in IndexCopernicus™
         liver disorders [1 related records]
         NASH [14 related records]
         Liver [1594 related records]


    Copyright © Medical Science Review - Hepatologia  2019
    Page created by Index Copernicus Ltd. All Rights reserved.